Marella Thorell's Net Worth
$770 Thousand
Who is Marella Thorell?
Marella Thorell does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Centessa Pharmaceuticals plc, ESSA Pharma Inc., Vallon Pharmaceuticals, Inc., Evelo Biosciences, Inc., Seres Therapeutics, Inc., and Carisma Therapeutics Inc..
SEC CIK
Marella Thorell's CIK is 0001826323
Past Insider Trading and Trends
2021 was Marella Thorell's most active year for acquiring shares with 6 total transactions. Marella Thorell's most active month to acquire stocks was the month of January. 2023 was Marella Thorell's most active year for disposing of shares, totalling 8 transactions. Marella Thorell's most active month to dispose stocks was the month of October. 2021 saw Marella Thorell paying a total of $20,000.00 for 430,417 shares, this is the most they've acquired in one year. In 2023 Marella Thorell cashed out on 201,845 shares for a total of $25,810.98, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Centessa Pharmaceuticals plc (CNTA) Snapshot price: $14.3
Chief Accounting Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +5,210.10% | 52.1K |
—
|
—
| 53.1K |
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
∞
| 1K |
$20.00 | $20,000.00 | 1K |
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 29 - May 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ESSA Pharma Inc. (EPIX) Snapshot price: $5.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Vallon Pharmaceuticals, Inc. (GRI) Snapshot price: $0.525
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -75.00% | -28.52K |
—
|
—
| 9.51K |
Dec 13
| |||
Form 4
|
∞
| 38.02K |
—
|
—
| 38.02K |
Jul 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Evelo Biosciences, Inc. (EVLO) Snapshot price: $0.0001
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +26.69% | 4.69K |
$0.33 | -$597.63 | 22.26K |
Scheduled
|
Nov 7 - Nov 8
| ||
Form 4
| +93.74% | 8.5K |
$0.33 | -$1,319.67 | 17.57K |
Scheduled
|
Nov 1 - Nov 2
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 11
| |||
Form 4
| +98.32% | 4.5K |
$9.51 | -$19,058.04 | 9.07K |
Aug 7 - Aug 8
| |||
Form 4
| -29.64% | -38.53K |
$0.13 | -$4,835.64 | 91.47K |
May 8
| |||
Form 4
|
∞
| 130K |
—
|
—
| 130K |
May 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Seres Therapeutics, Inc. (MCRB) Snapshot price: $1
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||